Roots Analysis recently published a report on the global Oncology Precision Medicine Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.

Market Size and Forecast

Current Market Size:USD 185 Billion

Future Market Size: USD 364 Billion

CAGR: 7.8%

Market Overview

This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments.

This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration.

Market Scope and Segmentation

- Historical Trend: Since 2018
- Forecast Period: Till 2035
- Market Size 2026: USD 185 Billion
- Market Size 2035: USD 364 Billion
- CAGR (Till 2035): 7.8%
- Type of Cancer Targeted
                • Bladder Cancer
                • Blood / Hematologic Cancer
                • Breast Cancer
                • Cervical Cancer
                • Gastrointestinal Cancer
                • Head and Neck Squamous Cell Cancer
                • Lung Cancer
                • Skin Cancer
                • Others
- Route of Administration
                • Oral
                • Intravenous
                • Others
- Type of Molecule
                • Small Molecules
                • Biologics
- Drug Class
                • Kinase Inhibitors
                • Enzyme Inhibitors
                • Immune Checkpoint Inhibitors
                • Others
- Leading Drug Developers
                • Merck
                • Pfizer
                • AstraZeneca
                • Johnson $ Johnson Innovative Medicine
                • Genentech
- Key Geographical Regions
                • North America (
                • Europe (
                • Asia (
                • Middle East and North Africa (
                • Latin America (
- Key Players
                • AbbVie
                • Anticancer Bioscience
                • Astellas Pharma
                • Astrazeneca
                • Bayer
                • Blueprint Medicines
                • Bristol Myers Squibb
                • Eli Lilly
                • Erasca
                • Genentech
                • GlaxoSmithKline
                • Hutchmed
                • IDEAYA Biosciences
                • Jiangsu Hengrui Pharmaceuticals
                • Johnson & Johnson Innovative Medicine
                • Merck
                • Novartis
                • Pfizer
                • Repare Therapeutics
                • Roche
                • Seagen
                • SpringWorks Therapeutics
                • Takeda Pharmaceutical
                • VERAXA Biotech GmbH
                • VRise Therapeutics
- PowerPoint Presentation (Complimentary): Available
- Customization Scope: 15% Free Customization
- Excel Data Packs (Complimentary)
                • Market Landscape
                • Partnerships and Collaborations
                • Clinical Trial Analysis
                • Case Study: Oncology Precision Medicine Assay Kits
                • Market Forecast and Opportunity Analysis

Read more: https://www.rootsanalysis.com/reports/oncology-precision-medicine-market.html

By Region

North America (, US, Canada, ), Europe (, France, Germany, Italy, Spain and UK, ), Asia (, China, Japan, Korea and India, ), Middle East and North Africa (, UAE, Israel, Qatar and Rest of Middle East and North Africa, ), Latin America (, Brazil, Argentina, Chile and Rest of Latin America, )

This segmentation structure provides a clear framework for understanding market dynamics, segment-specific trends, and growth opportunities.

Technological and Strategic Insights

The Roots Analysis report includes a detailed assessment of:

• Technological advancements and R&D activity
• Innovations in formulation and delivery methods
• Marketing and distribution strategies
• Pricing models and cost structures
• Manufacturing capacities and supply chain trends

These insights are presented neutrally, supported by empirical evidence and primary research validation.

Key Market Players

Profiles of prominent companies include:

AbbVie, Anticancer Bioscience, Astellas Pharma, Astrazeneca, Bayer, Blueprint Medicines, Bristol Myers Squibb, Eli Lilly, Erasca, Genentech, GlaxoSmithKline, Hutchmed, IDEAYA Biosciences, Jiangsu Hengrui Pharmaceuticals, Johnson & Johnson Innovative Medicine, Merck, Novartis, Pfizer, Repare Therapeutics, Roche, Seagen, SpringWorks Therapeutics, Takeda Pharmaceutical, VERAXA Biotech GmbH, VRise Therapeutics

Each profile highlights:

• Product portfolio and focus areas
• Operational footprint and regional presence
• Financial and strategic performance
• Recent developments (e.g., partnerships, market entries, acquisitions)

Regional Insights

Each region is analyzed based on:

• Historical and current market size
• Revenue performance
• Contribution to global share
• Strategic developments and regional trends

Comparative insights across regions enable targeted market entry and expansion strategies.

Report Structure

• Part 01: Market Overview
• Part 02: Market Size, by Regions
• Part 03: Market Revenue, by Countries
• Part 04: Market Competition, by Key Players
• Part 05: Company Profiles